Nutritional stress and arginine auxotrophy confer high sensitivity to chloroquine toxicity in mesothelioma cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 46, Issue 4, 2012, Pages 498-506

  Battisti, Sonia ^a   Valente, Davide ^a   Albonici, Loredana ^a   Bei, Roberto ^a   Modesti, Andrea ^a   Palumbo, Camilla ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Argininosuccinate synthetase; Autophagy; Chloroquine; Malignant mesothelioma; Nutritional stress

Indexed keywords

ARGININE; ARGININOSUCCINATE SYNTHASE; CHLOROQUINE;

ARTICLE; AUTOPHAGY; AUXOTROPHY; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER TISSUE; CELL DEATH; CELL STRESS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; HUMAN; HUMAN CELL; HYPOTHESIS; MESOTHELIOMA; NUTRITION; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; STANDARD; TUMOR MICROENVIRONMENT;

ARGININE; ARGININOSUCCINATE SYNTHASE; AUTOPHAGY; CELL DEATH; CELL LINE, TUMOR; CHLOROQUINE; HUMANS; MESOTHELIOMA; STRESS, PHYSIOLOGICAL; TUMOR MICROENVIRONMENT;

EID: 84859400805     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2011-0195OC     Document Type: Article

References (46)

1. Solomon VR, Lee H. Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. Eur J Pharmacol 2009;625:220-233.
2. Livesey KM, Tang D, Zeh HJ, Lotze MT. Autophagy inhibition in combination cancer treatment. Curr Opin Investig Drugs 2009;10: 1269-1279.
3. Rabinowitz JD, White E. Autophagy and metabolism. Science 2010;330: 1344-1348.
4. Levine B, Yuan J. Autophagy in cell death: an innocent convict? J Clin Invest 2005;115:2679-2688. (Pubitemid 41434392)
5. Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004;23:2891-2906. (Pubitemid 38638851)
6. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, Mukherjee C, Shi Y, Gélinas C, Fan Y, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006;10:51-64.
7. White E. Role of the metabolic stress responses of apoptosis and autophagy in tumor suppression. Ernst Schering found Symp Proc 2007;4: 23-34.
8. Kuma A, Mizushima N. Physiological role of autophagy as an intracellular recycling system: with an emphasis on nutrient metabolism. Semin Cell Dev Biol 2010;21:683-690.
9. Boya P, Gonzàlez-Polo RA, Casares N, Perfettini JL, Dessen P, Laraochette N, Métivier D, Meley D, Souquere S, Yoshimori T, et al. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 2005; 25:1025-1040. (Pubitemid 40165810)
10. Maiuri MC, Tasdemir E, Criollo A, Morselli E, Vicencio JM, Carnuccio R, Kroemer G. Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ 2009;16:87-93.
11. Armstrong JL, Corazzari M, Martin S, Pagliarini V, Falasca L, Hill DS, Ellis N, Al Sabah S, Redfern CP, Fimia GM, et al. Oncogenic B-RAF signalling in melanoma impairs the therapeutic advantage of autophagy inhibition. Clin Cancer Res 2011;17:2216-2226.
12. Guo JY, Chen HY, Mathew R, Fan J, Strohecker AM, Karsli-Uzunbas G, Kamphorst JJ, Chen G, Lemons JM, Karantza V, et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 2011;25:460-470.
13. Attanoos RL, Gibbs AR. Pathology of malignant mesothelioma. Histopathology 1997;30:403-418. (Pubitemid 27240380)
14. Pisick E, Salgia R. Molecular biology of malignant mesothelioma: a review. Hematol Oncol Clin North Am 2005;19:997-1023. (Pubitemid 41736039)
15. Palumbo C, Bei R, Procopio A, Modesti A. Molecular targets and targeted therapies for malignant mesothelioma. Curr Med Chem 2008; 15:855-867. (Pubitemid 351736408)
16. Artenstein AW, Opal SM, Cristofaro P, Palardy JE, Pareio NA, Green MD, Jhung JW. Chloroquine enhances survival in Bacillus anthracis intoxication. J Infect Dis 2004;190:1655-1660. (Pubitemid 39411016)
17. Kalia S, Dutz JP. New concepts in antimalarial use and mode of action in dermatology. Dermatol Ther 2007;20:160-174. (Pubitemid 350029307)
18. Reale FR, Griffin TW, Compton JM, Graham S, Townes PL, Bogden A. Characterization of a human malignant mesothelioma cell line (H-MESO-1): a biphasic solid and ascitic tumor model. Cancer Res 1987;47:3199-3205. (Pubitemid 17082649)
19. Versnel MA, Bouts MJ, Hoogsteden HC, van der Kwast TH, Delahaye M, Hagemeijer A. Establishment of human malignant mesothelioma cell lines. Int J Cancer 1989;44:256-260. (Pubitemid 19217211)
20. Catalano A, Romano M, Robuffo I, Strizzi L, Procopio A. Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity. Am J Pathol 2001;159:721-731. (Pubitemid 32751102)
21. Schramm A, Opitz I, Thies S, Seifert B, Moch H, Weder W, Soltermann A. Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma. Eur J Cardiothorac Surg 2010;37: 566-572.
22. Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc 2006;1:1112-1116.
23. Palumbo C, Albonici L, Bei R, Bocci C, Scarpa S, Di Nardo P, Modesti A. HMBA induces cell death and potentiates doxorubicin toxicity in malignant mesothelioma cells. Cancer Chemother Pharmacol 2004;54: 398-406. (Pubitemid 39462964)
24. Shi CS, Kehrl JH. MyD88 and Trif target Beclin 1 to trigger autophagy in macrophages. J Biol Chem 2008;283:33175-33182.
25. Zhang H, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, Wesley JB, Gonzalez FJ, Semenza GL. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem 2008; 283:10892-10903.
26. Bjørkøy G, Lamark T, Pankiv S, Øvervatn A, Brech A, Johansen T. Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol 2009;452:181-197.
27. Szlosarek PW, Klabatsa A, Pallaska A, Sheaff M, Smith P, Crook T, Grimshaw MJ, Steele JP, Rudd RM, Balkwill FR, et al. In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion. Clin Cancer Res 2006;12:7126-7131. (Pubitemid 44974513)
28. Mun GI, Kim IS, Lee BH, Boo YC. Endothelial argininosuccinate synthetase 1 regulates nitric oxide production and monocyte adhesion under static and laminar shear stress conditions. J Biol Chem 2011; 286:2536-2542.
29. Mizushima N, Yoshimori T. How to interpret LC3 immunoblotting. Autophagy 2007;3:542-545. (Pubitemid 350060049)
30. Nicholson LJ, Smith PR, Hiller L, Szlosarek PW, Kimberley C, Sehouli J, Koensgen D, Mustea A, Schmid P, Crook T. Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer. Int J Cancer 2009;125:1454-1463.
31. Huang X, Bai HM, Chen L, Li B, Lu YC. Reduced expression of LC3-BII and Beclin 1 in glioblastoma multiforme indicates a down-regulated autophagic capacity that relates to the progression of astrocytic tumors. J Clin Neurosci 2010;17:1515-1519.
32. Wei Y, Shina S, Levine B. Dual role of JNK1-mediated phosphorylation of Bcl-2 in autophagy and apoptosis regulation. Autophagy 2008;4: 949-951.
33. Barth S, Glick D, Macleod KF. Autophagy: assays and artifacts. J Pathol 2010;221:117-124.
34. Kobayashi S, Volden P, Timm D, Mao K, Xu X, Liang Q. Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death. J Biol Chem 2010;285:793-804.
35. Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell 2010;140:313-326.
36. Delage B, Fennell DA, Nicholson L, McNeish I, Lemoine NR, Crook T, Szlosarek PW. Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer. Int J Cancer 2010;126:2762-2772.
37. Hatzoglou M, Fernandez J, Yaman I, Closs E. Regulation of cationic amino acid transport: the story of the CAT-1 transporter. Annu Rev Nutr 2004;24:377-399. (Pubitemid 38938797)
38. Wheatley DN, Scott L, Lamb J, Smith S. Single amino acid (arginine) restriction: growth and death of cultured HeLa and human diploid fibroblasts. Cell Physiol Biochem 2000;10:37-55.
39. Durante W. Regulation of L-arginine transport and metabolism in vascular smooth muscle cells. Cell Biochem Biophys 2001;35:19-34.
40. van der Heijden JW, Dijkmans BA, Scheper RJ, Jansen G. Drug insight: resistance to methotrexate and other disease-modifying antirheumatic drugs - from bench to bedside. Nat Clin Pract Rheumatol 2007;3:26-34.
41. Komatsu M, Waguri S, Kioke M, Sou YS, Ueno T, Hara T, Mizushima N, Iwata J, Ezaki J, Murata S, et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 2007;131:1149-1163. (Pubitemid 350235021)
42. Shvets E, Fass E, Scherz-Shouval R, Elazar Z. The N-terminus and Phe52 residue of LC3 recruit p62/SQSTM1 into autophagosomes. J Cell Sci 2008;121:2685-2695.
43. Kuo MT, Savaraj N, Feun LG. Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes. Oncotarget 2010;1:246-251.
44. Kim RH, Coates JM, Bowles TL, McNerney GP, Sutcliffe J, Jung JU, Gandour-Edwards R, Chuang FY, Bold RJ, Kung HJ. Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. Cancer Res 2009;69:700-708.
45. Zheng Y, Zhao YL, Deng X, Yang S, Mao Y, Li Z, Jiang P, Zhao X, Wei Y. Chloroquine inhibits colon cancer cell growth in vitro and tumor growth in vivo via induction of apoptosis. Cancer Invest 2009;27:286-292.
46. Jiang PD, Zhao YL, Deng XQ, Mao YQ, Shi W, Tang QQ, Li ZG, Zheng YZ, Yang SY, Wei YQ. Antitumor and antimetastatic activities of chloroquine in a murine model of breast cancer. Biomed Pharmacother 2010;64:609-614.